Customised immune-blocking medication may be the key to treating patients with motor neurone disease (MND), which currently has no cure and limited therapeutic options.
17 February 2020Search UQ News
Customised immune-blocking medication may be the key to treating patients with motor neurone disease (MND), which currently has no cure and limited therapeutic options.
17 February 2020
Privacy & Terms of use | Feedback
Authorised by: Director, Office of Marketing and Communications
ABN: 63 942 912 684
CRICOS
Provider No: 00025B